S. Bilgen

Aspirin resistance in systemic lupus erythematosus. A pilot study

A. Akdoğan, O. Karadag, L. Kılıç, 2013, Lupus.

SAT0216 Abatacept experience in biologic naive rheumatoid arthritis patients: hur-bio real life results

A. Akdoğan, A. Erden, B. Armağan, 2017 .

FRI0140 Comorbidity and surgery history of rheumatoid arthritis patients who are receiving biological agent

A. Akdoğan, A. Erden, B. Armağan, 2017 .

AB0661 Significance and Timing of Imaging in Takayasu's Arteritis

A. Akdoğan, U. Kalyoncu, O. Karadag, 2015 .

Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases

S. Özen, A. Akdoğan, A. Erden, 2017, Scandinavian journal of rheumatology.

Comparison of demographic, clinic and radiological features of patients with axial spondyloarthritis accompanying familial Mediterranean fever to patients with each condition alone

A. Akdoğan, U. Kalyoncu, O. Karadag, 2022, Scandinavian journal of rheumatology.

AB0416 CARDIOVASCULAR EVENT, VENOUS THROMBOEMBOLIZM, AND INFECTION RISK WITH TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS AGED ≥ 60 YEARS

A. Akdoğan, U. Kalyoncu, O. Karadag, 2022, Annals of the Rheumatic Diseases.

THU0131 Premature coronary heart disease frequency in rheumatoid arthritis who are receiving biologic agents: hur-bio real life results

A. Akdoğan, A. Erden, B. Armağan, 2017 .